Why hospitals, post-acute providers, and AI vendors choose Clinovian — by service.
What teams use today, where it falls short, and the specific edge Clinovian offers — clinical and operational — for each deliverable.
Every service is one application of a single, hard-to-copy engine: apply real payer-side utilization-management methodology — review discipline built applying InterQual and MCG criteria on the payer side — to a denied case, then map the record evidence directly to the criterion the reviewer is evaluating. The economic model reinforces it: one de-identified scope review for prospective clients, a fixed price per deliverable, and a turnaround that competes with a calendar, not a hiring cycle.
These are partner workflows, not competitors. Coders and CDI specialists excel at documentation accuracy and first-pass denial management; appeal writers handle formatting and submission; AI tools draft language quickly. Clinovian adds the one layer none of them are built to supply — the physician-level medical-necessity judgment a payer reviewer is actually evaluating against. The only line ever drawn is scope of practice, not capability. Complementary, not competitive.
Describe the case
"The patient was acutely ill with sepsis and required ICU-level care."
Clinically true — and what most appeals say. The payer reviewer isn't evaluating whether the patient was sick; they're evaluating whether the chart satisfies a specific criterion within a specific pathway.
Map to the criteria
"The documented hemodynamic instability and organ-failure markers satisfy inpatient severity under the payer-applied sepsis pathway, specifically through the escalation-of-intervention threshold."
The reviewer can see the exact criterion being answered, with record evidence mapped to the decision logic — not general clinical disagreement.
Six structural advantages every service inherits.
None of these is a tactic a competitor can copy by trying harder. Each is built into how Clinovian is structured, priced, or staffed.
| Advantage | What it replaces | Why it can't be copied |
|---|---|---|
| Payer-side UM vantage | Outside-in clinical opinion | You must have sat in the seat that approves and denies — InterQual/MCG applied to 3,000+ real claims. |
| Criteria-mapped, not narrative | Generic clinical-story appeals | The output maps record evidence to the reviewer's own decision logic, not a well-written summary of the chart. |
| De-identified initial scope review | Committing before confirming scope and required records | One de-identified matter is screened for service fit, likely value of physician review, required documents, and the appropriate paid engagement. |
| Fixed fee, never hourly | The hourly consultant meter | Flat per-deliverable pricing removes any incentive to over-work a weak case. |
| 48–72h memo turnaround | Weeks on an FTE physician advisor's calendar | A scoped desk engagement compresses in a way a single hire's bandwidth structurally cannot. |
| Complements, doesn't replace | A parallel workflow competing with your team | The memo hands the argument back to your coders, appeal writers, or AI tool — it was never built to take over submission. |
The recurring pattern: one initial scope review removes the friction of confirming fit and required records, while fixed-fee paid work prevents an open-ended billing meter. The larger commitment — an evaluation package, then recurring capacity — follows only after the fit is clear.
What each audience uses today, and where Clinovian fits.
Same engine, three different intake points. Each table compares what the audience reaches for today against the specific edge the desk adds — service by service.
| Service | Today they use… | The Clinovian difference | In one line |
|---|---|---|---|
| Medical-Necessity Escalation Memo | Narrative appeal language without criteria-pathway mapping | Physician-authored, criteria-mapped argument in a fixed 12-section format your appeal writer can use directly. | The argument the payer reviewer is trained to recognize. |
| Observation vs. Inpatient Defense | A general clinical-severity narrative applied after the stay is over | Prospective Two-Midnight Rule reasoning tied to admission-time clinical judgment — the only basis the rule recognizes. | Argue admission status the way CMS actually evaluates it. |
| DRG-Downgrade Challenge | Often unchallenged — the claim was paid, not denied, so it never reaches a denial queue | Full chart reconstruction with severity markers and coding-principle framing that complements your CDI team. | Surfaces the paid-but-downgraded disputes your denial dashboard never shows you. |
| Peer-to-Peer Prep Brief | The treating physician walks in with the clinical story, not the criteria | A criteria-mapped briefing built around the payer's likely decision logic and objections. | Prepares the physician for the evaluation the reviewer is actually running. |
| Pre-Denial Necessity Dossier | Wait for the denial, then appeal it | Physician-authored argument submitted before the payer decides, so the first answer is more often yes. | The argument arrives before the denial does. |
| Service | Today they use… | The Clinovian difference | In one line |
|---|---|---|---|
| SNF / IRF / LTACH / Home Health Denials | Clinical updates that restate stability rather than ongoing skilled need | Separates the two questions payers conflate — acute stability vs. continued skilled-care necessity. | Answers the question the denial actually turns on. |
| Federal-Oversight-Informed Appeals | Appeals written without referencing what regulators have already documented about this category | Positions the appeal against published oversight findings on post-acute denial-overturn patterns. | Your strongest argument may already be in a federal report. |
| Two-Midnight Rule & LOC Defense | Retrospective severity arguments made after the stay has ended | Prospective, admission-time clinical-judgment reasoning — the only basis the rule recognizes. | The rule is prospective. Most appeals aren't. This one is. |
| Service | Today they use… | The Clinovian difference | In one line |
|---|---|---|---|
| AI Appeal Clinical QA | AI-drafted appeals submitted without independent clinical review | Independent physician check for hallucinated claims, weak criteria logic, and overstatement before the payer sees it. | A clinical check on whatever your AI already drafted. |
| RCM Partner Escalation (white-label) | Hard cases sit unescalated, or get routed to an expensive full-time hire | An embedded physician layer your team can flex up or down without a payroll commitment. | Physician-grade escalation under your own brand. |
| No-PHI Clinical Denial AR Audit | Aged denial inventory triaged by dollar value alone, not clinical pursuability | 72-hour physician triage flags what's contestable, deadline-urgent, and worth pursuing first — no PHI required to start. | Find the clinically contestable accounts before spending an appeal-writer's hour on them. |
| NSA/IDR Clinical Value Dossier | Generic submissions that do not connect the clinical record to the permissible considerations the certified IDR entity may weigh | Only relevant, supported circumstances addressed — with a physician-authored acuity and complexity narrative. | Complex IDR disputes need clinical evidence, not a sixth-factor template or portal filing service. |
What the desk does — and what the alternatives do differently.
Clinovian Clinical Escalation Desk
Fixed-scope physician memo with criteria-mapped reasoning. 48–72 hour turnaround. No FTE cost. Scale up or down monthly. Pattern intelligence compounds over time. Best for: teams with 5–30+ clinical escalations per month who need physician-grade reasoning without a full-time hire.
Full-Time Physician Advisor
One current U.S. hospital posting listed $206,606–$413,212 before benefits and overhead. Covers broader scope: UM committee, CDI education, real-time concurrent review, and licensed capability. Recruitment can take months, a single advisor has capacity limits, and the fixed cost runs regardless of volume. Clinovian and physician advisors are complementary — advisors use the desk for overflow and out-of-scope specialty cases.
Outsource to RCM Firm
Full-service revenue cycle outsourcing. Handles volume well, but physician-level escalation capability is typically absent — which is why RCM firms themselves are among Clinovian's primary partners, embedding the desk into their denial operations.
Do Nothing / Internal Only
Works for routine billing, eligibility, and coding denials. Does not work for medical-necessity denials that turn on criteria interpretation, comorbidity burden, or level-of-care logic. The cases that stall on the dashboard are the ones that need the desk.
The math behind the entry point: a $1,000 three-case evaluation is a small fraction of what a single recovered medical-necessity case is worth, and a smaller fraction still of one month of a full-time advisor's salary. Its job is to prove the reasoning quality before either side commits further.
Guardrails — what Clinovian never claims.
The integrity of the work product depends on what we don't say as much as what we do.
Every framing is fee versus dollars at stake, never a guaranteed result. The memo shapes the argument; the determination belongs to the payer or certified IDR entity.
Clinical-necessity reasoning supporting the appeal — never legal advice. Filing decisions and jurisdiction-specific strategy stay with client counsel.
"The clinical QA layer your pipeline doesn't have" — never "better than your model." Clinovian validates AI-drafted output; it does not compete with the tool that drafted it.
The deliverable is physician-led clinical reasoning and criteria-mapped analysis — not a licensed clinical opinion. Where a case requires formal U.S.-licensed sign-off, that stays with the client's own licensed clinical staff or designated reviewer.
See the argument quality before you commit.
Start with a 3-case evaluation. The work speaks for itself.